Neurosense Therapeutics Ltd. ( ($NRSN) ) has issued an announcement. NeuroSense Therapeutics Ltd. announced on November 24, 2025, that it has ...

Paragon's Age of Intellect update brings a new hero into the mix. Phase, the new ranged Support is available to play Tuesday, May 16 Paragon is the MOBA from Epic Games that puts you in the fight with ...

Therapeutics announced that the U.S. Food and Drug Administration has completed the review of the Investigational New Drug ...

TUCSON, Ariz., July 10, 2019 /PRNewswire/ -- Paragon Space Development Corporation (Paragon) is now under contract with NASA to mature its Condensate Separator for Microgravity Conditions (COSMIC) ...

Throw your teammates a lifeline as Phase, the new ranged Support in Paragon. Paragon is the MOBA from Epic Games that puts you in the fight with explosive action, direct third-person control, and deep ...

CHICAGO, Nov. 10, 2021 /PRNewswire/ -- Emalex Biosciences, Inc. ("Emalex"), a biopharmaceutical company founded by Paragon Biosciences to develop treatments for central nervous system movement ...

Phase II study of oral ENMD-2076 administered to patients with ovarian clear cell carcinoma: A trial of the Princess Margaret Phase II Consortium. Background: Gynaecological cancers of several ...

(RTTNews) - Swiss drug major Novartis AG (NVS) announced Monday that the global Phase III PARAGON-HF study in heart failure patients with preserved ejection fraction or HFpEF narrowly missed ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

NeuroSense receives US FDA clearance to begin pivotal phase 3 trial for PrimeC in ALS: Cambridge, Massachusetts Wednesday, November 26, 2025, 13:00 Hrs [IST] NeuroSense Therapeuti ...